AIDS activists work to influence Kenyan presidential candidates' positions on care, treatment

"A small team of HIV/AIDS activists is trailing Kenyan presidential candidates as they crisscross the country, pressing them to increase their commitment to the care and treatment of people living with HIV," PlusNews reports. "The 17 activists, who come from a range of civil society organizations, are calling on each of the eight presidential candidates to sign a manifesto guaranteeing a scale-up of HIV-testing, the elimination of mother-to-child transmission, and accelerated rollout of antiretroviral therapy (ART)," and they "are saying they can help deliver votes from many of the more than one million Kenyans living with HIV to the candidates most willing to address their concerns," according to the news service. "Kenya faces a funding gap for its HIV programs estimated at $1.67 billion. And although the country has steadily increased the number of people on ART, more than 100,000 HIV-positive Kenyans who need the drugs have no access to them," PlusNews writes, adding, "Yet the presidential candidates have largely been silent on the issue" (2/25).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative HIV vaccine approaches yield potential for broad protection against viral strains